Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionCerity Partners LLC
Latest Disclosed Ownership209,931 shares
Latest Disclosed Value $ 16,811,314
Cerity Partners LLC reports 3.48% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 15, 2026 - Cerity Partners LLC filed a 13F-HR form disclosing ownership of 209,931 shares of Edwards Lifesciences Corporation (US:EW) valued at $16,811,274 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 217,507 shares of Edwards Lifesciences Corporation. This represents a change in shares of -3.48% during the quarter. The current value of the position is $18,054,066 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 209,931 -7,576 -3.48 16,811 -9.34 0.0118
2026-02-11 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 217,507 4,802 2.26 18,542 12.09 0.0270
2025-10-22 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 212,705 7,545 3.68 16,542 3.10 0.0268
2025-08-13 2025-06-30 13F EDWARDS LIFESCIENCES Stock 28176E108 205,160 -7,763 -3.65 16,046 3.97 0.0286
2025-04-30 2025-03-31 13F EDWARDS LIFESCIENCES Stock 28176E108 212,923 86,089 67.88 15,433 67.61 0.0313
2025-02-13 2024-12-31 13F EDWARDS LIFESCIENCES Stock 28176E108 126,834 4,012 3.27 9,207 13.61 0.0200
2024-11-12 2024-09-30 13F EDWARDS LIFESCIENCES Stock 28176E108 122,822 -75,611 -38.10 8,105 -55.79 0.0179
2024-08-13 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 198,433 -13,517 -6.38 18,329 -9.50 0.0483
2024-05-14 2024-03-31 13F EDWARDS LIFESCIENCES Equities 28176E108 211,950 -168,074 -44.23 20,254 -30.11 0.0535
2024-01-26 2023-12-31 13F EDWARDS LIFESCIENCES Equity 28176E108 380,024 -14,121 -3.58 28,977 6.12 0.0952
2023-11-14 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 394,145 -53,072 -11.87 27,306 -35.27 0.1328
2023-08-14 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 447,217 259,097 137.73 42,186 170.92 0.1643
2023-05-11 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 188,120 188,120 15,572 0.0367
2022-11-10 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 0 -35,604 -100.00 0 -100.00
2022-08-10 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 35,604 35,604 3,386 0.0374
2022-02-14 2021-12-31 13F Edwards Lifesciences Stock 28176E108 0 -36,300 -100.00 0 -100.00
2021-10-25 2021-09-30 13F Edwards Lifesciences Stock 28176E108 36,300 -31 -0.09 4,110 9.22 0.0904
2021-08-11 2021-06-30 13F EDWARDS LIFESCIENCES Stock 28176E108 36,331 1,041 2.95 3,763 27.47 0.0824
2021-08-11 2021-03-31 13F/A-1 EDWARDS LIFESCIENCES Stock 28176E108 35,290 -579 -1.61 2,952 -9.78 0.0701
2021-05-12 2021-03-31 13F EDWARDS LIFESCIENCES Stock 28176E108 35,265 -604 2,950 0.0874
2021-02-11 2020-12-31 13F EDWARDS LIFESCIENCES Stock 28176E108 35,869 -2,706 -7.01 3,272 6.27 0.1049
2020-11-12 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 38,575 3,927 11.33 3,079 28.56 0.1267
2020-08-17 2020-06-30 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 34,648 23,127 200.74 2,395 10.22 0.1323
2020-08-14 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 34,761 23,240 2,402 132,476.0446
2020-05-14 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,521 -564 -4.67 2,173 -22.92 0.1368
2020-02-14 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 12,085 340 2.89 2,819 9.14 0.1437
2019-10-30 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,745 219 1.90 2,583 21.32 0.1516
2019-08-14 2019-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,526 -1,103 -8.73 2,129 -11.88 0.1342
2019-05-14 2019-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 12,629 -36 -0.28 2,416 24.54 0.1627
2019-02-06 2018-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 12,665 -1,247 -8.96 1,940 -19.90 0.1299
2018-11-15 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 13,912 747 5.67 2,422 26.41 0.1677
2018-08-15 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 13,165 93 0.71 1,916 5.04 0.1416
2018-05-15 2018-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 13,072 -61 -0.46 1,824 23.24 0.1395
2018-02-14 2017-12-31 13F Edwards Lifesciences COM 28176E108 13,133 -560 -4.09 1,480 -1.14 0.0993
2017-11-13 2017-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 13,693 13,693 1,497 0.1060
2017-08-10 2017-06-30 13F Edwards Lifesciences COM 28176E108 0 -13,056 -100.00 0 -100.00
2017-05-02 2017-03-31 13F Edwards Lifesciences COM 28176E108 13,056 13,056 1,228 0.1025
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.